REVIA
REVIA
Approved
DIN Number
02213826
Drug Class
Human
Market Date
Oct 23, 1997
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02213826
AIG Number0118591001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07BB04 NALTREXONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:10.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
NALTREXONE HYDROCHLORIDEActive
Strength: 50 MG
Monograph: NALTREXONE HYDROCHLORIDE